Lawmakers Push FDA To Withdraw Guidance On Compounding, Issue Rule Allowing Practice

A bipartisan coalition of 65 lawmakers is demanding FDA rescind a controversial guidance prohibiting pharmacies overseen by states from compounding without, or in anticipation of, an individual prescription, and instead issue a proposed rule allowing office-use compounding where authorized by state law. The push from lawmakers came the same day the agency ignored calls from appropriators for FDA to issue guidance allowing office-use compounding. While both groups of lawmakers allege FDA is acting against congressional intent, the agency appears to...